Facilitated By

San Antonio Medical Foundation

Development of a Monoclonal Antibody Product to Diminish Apoptosis in Diabetic Renal, Ocular and Vascular Complications

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Richard LeBaron
Funded by
San Antonio Area Fdn
Research Start Date
Status
Active

Basic Research

Collaborative Project
Basic Research
Biomechanics
Drug Discovery
Diabetes and Obesity
Cardiovascular